- Elutia (ELUT, Financial) to present at Chardan's Trending Issues in Drug Development Conference Series.
- Focus of presentation: 'Data & Regulatory Catalysts – Navigating an Evolving Landscape'.
- Event takes place on April 29, 2025, with a live webcast available for investors.
Elutia Inc. (ELUT), a leader in drug-eluting biomatrix technologies, is set to participate in Chardan’s Trending Issues in Drug Development Conference Series. The company has announced that its Chief Scientific Officer, Dr. Michelle LeRoux Williams, will take part in a fireside chat during the event. The discussion will center around 'Data & Regulatory Catalysts – Navigating an Evolving Landscape' and is scheduled for Tuesday, April 29, 2025, at 11:00 a.m. ET.
This virtual event will be accessible to investors and interested parties via a live webcast. Additionally, an archived version of the presentation will be available on Elutia’s investor relations website at investors.elutia.com after the event.
Elutia's participation in this conference highlights the company's commitment to advancing drug-eluting biomatrix technologies, which aim at improving the compatibility between medical devices and patients. As the demand for implantable technologies grows, Elutia's mission to humanize medicine and enable patients to thrive without compromise remains at the forefront of its operations.
